Industry Reports
QPSI Announces Acquisition Of Pharmaceutical Packaging Company, International Labs
Quality Packaging Specialists International, LLC (QPSI) has acquired 100% ownership of International Labs, LLC (INL) in an equity exchange transaction. Terms...
News
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma
GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. ...
News
Intarcia Announces FDA Filing Acceptance of NDA for ITCA 650 for the Treatment of Type 2 Diabetes
Intarcia Therapeutics, Inc. announced that the U.S. FDA has accepted for active review its NDA for ITCA 650, an investigational therapy for the treatment...
Clinical Trials
Envisia therapeutics releases interim Env515 phase 2 data results
Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology released an interim analysis of the second cohort...
Press Releases
Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. ...
Press Releases
MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS
MeiraGTx, a New York and UK based gene therapy company, announced that it has been awarded a grant from Target ALS, a privately funded...
Drug Research
Sanofi and Regeneron Announce First Approval of KevzaraTM for the Treatment of Moderately
Sanofi and Regeneron Pharmaceuticals, Inc announced that Health Canada approved KevzaraTM (sarilumab), an interleukin-6 (IL-6) receptor antibody. For the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read